MRK vs NVO
Merck & Co. vs Novo Nordisk A/S — AI-powered side-by-side comparison
| Metric | MRK | NVO |
|---|---|---|
| AI Score | 56 | 56 |
| Price | $123.48 | $49.48 |
| P/E Ratio | 34.71× | 11.75× |
| ROE | 17.9% | 66.4% |
| Revenue Growth YoY | 2.9% | 8.1% |
| Gross Margin | 78.1% | 81.8% |
| Debt / Equity | 0.94× | 0.67× |
| Dividend Yield | 2.7% | 3.7% |
| RSI (14) | 45.9 | 65.6 |
| Beta | 0.21 | 1.8569 |
| Expected Upside | +0.4% | +25.9% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
NVO Full Analysis